Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: A phase II study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination therapy with capecitabine and interferon alfa-2A in patients with advanced renal cell carcinoma: A phase II study

Published:2004-09 Issue:5 Volume:22 Page:387-392
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Padrik Peeter,Leppik Krista,Arak Andrus

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference34 articles.

1. Estimating the world cancer burden;Parkin;Int J Cancer,2001

2. Global cancer statistics;Parkin;CA Cancer J Clin,1999

3. Renal cell carcinoma;Savage;Curr Opin Oncol,1996

4. Chemotherapy for advanced renal-cell carcinoma;Yagoda;Semin Oncol,1995

5. Chemotherapy for renal cell carcinoma;Hartmann;Anticancer Res,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinoma;Expert Opinion on Investigational Drugs;2018-01-24

2. Chemotherapy in metastatic renal cell carcinoma today? A systematic review;Anti-Cancer Drugs;2013-07

3. A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer;Cancer Chemotherapy and Pharmacology;2009-09-22

4. Different responses to two types of 5-fluorouracil prodrugs in combination with interferon-alpha in pulmonary metastases of renal cell carcinoma: a case report;Cases Journal;2009-05-26

5. The Combination of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma—Is Not the Answer;American Journal of Clinical Oncology;2008-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3